{"gene":"RD3","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2006,"finding":"RD3 protein exhibits subnuclear localization adjacent to promyelocytic leukemia (PML) bodies in transiently transfected COS-1 cells; the truncated mutant RD3 protein is rapidly degraded in COS-1 cells.","method":"Transient transfection of COS-1 cells with RD3-fusion protein, immunofluorescence microscopy","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 — single transfection experiment, localization without full functional link established","pmids":["17186464"],"is_preprint":false},{"year":2010,"finding":"RD3 colocalizes and physically interacts with guanylate cyclases GC1 and GC2 in rod and cone photoreceptor cells; in rd3 mice deficient in RD3, GC1 and GC2 are undetectable in photoreceptors; cell expression studies show RD3 mediates export of GC1 from the endoplasmic reticulum to endosomal vesicles, and the C-terminus of GC1 is required for RD3 binding.","method":"Co-immunoprecipitation from retinal cell extracts and HEK293 cells, immunofluorescence microscopy of rd3 mouse retinas, cell expression trafficking assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, loss-of-function mouse model with defined cellular phenotype, trafficking assay; replicated in follow-up studies","pmids":["21078983"],"is_preprint":false},{"year":2011,"finding":"RD3 is a high-affinity allosteric inhibitor of retinal membrane guanylyl cyclase (RetGC), suppressing basal RetGC activity in a noncompetitive manner at submicromolar concentrations and inhibiting GCAP-stimulated RetGC activity at low Ca2+; disease-associated mutations (including the LCA12 C-terminal truncation and G57V) reduce RD3's affinity for RetGC1 or abolish inhibitory activity; inhibition of RetGC by RD3 may function to block cyclase activity during its maturation/trafficking.","method":"In vitro RetGC activity assays with purified or expressed RD3 and RetGC1/GCAP, site-directed mutagenesis of disease-associated RD3 variants, HEK293 cell expression","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution assay with mutagenesis, multiple disease-associated mutants tested, replicated by subsequent studies","pmids":["21928830"],"is_preprint":false},{"year":2013,"finding":"AAV8-mediated delivery of Rd3 cDNA to rd3 mouse photoreceptors restores GC1 and GC2 translocation from the ER to rod and cone outer segments, rescues photoreceptor survival for at least 7 months, and restores rod and cone visual function as measured by ERG; this confirms RD3's essential role in GC exit from the ER and trafficking to outer segments.","method":"Subretinal AAV injection, immunofluorescence microscopy, electroretinography, photoreceptor cell counting","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — in vivo gene rescue with multiple orthogonal readouts (immunolocalization, ERG, cell survival), clear functional consequence","pmids":["23740938"],"is_preprint":false},{"year":2016,"finding":"The main RetGC-binding interface on RD3 required for negative regulation of the cyclase maps to the Lys87–Leu122 central region; substitutions in four conserved regions—(87)KIHP(90), (93)CGPAI(97), (99)RFRQ(102), and (119)RSVL(122)—reduced apparent RD3 affinity for the cyclase 180–700-fold; mutations in (93)CGPAI(97) (especially Cys93) most drastically disrupted RD3 co-localization with RetGC1 in HEK293 cells.","method":"Alanine/sequence-scramble mutagenesis of conserved RD3 regions, in vitro RetGC inhibition assays, co-localization in co-transfected HEK293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis across 22 regions combined with in vitro activity assay and cell co-localization","pmids":["27471269"],"is_preprint":false},{"year":2018,"finding":"NMR solution structure of human RD3 (residues 18–160) reveals an elongated four-helix bundle (~70 Å × 30 Å) with a long unstructured loop between helices 1 and 2; residues previously implicated in RetGC binding map to a localized contiguous area involving the loop between helices 2 and 3 and adjacent parts of helices 3 and 4; mutagenesis of hydrophobic core residues (Trp85, Phe29, Glu32, Cys93) validated the structure and its relevance to RetGC1 binding affinity.","method":"NMR solution structure determination, site-directed mutagenesis, in vitro RetGC binding/inhibition assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with mutagenesis functional validation; monomeric soluble variant used","pmids":["30559291"],"is_preprint":false},{"year":2019,"finding":"RD3 protects photoreceptors from degeneration by competing with GCAPs for RetGC binding; in rd3/rd3 retinas, residual RetGC is stimulated by GCAPs at low Ca2+; ablation of GCAPs in rd3/rd3 mice rescued ~70% of photoreceptors past 6 months (vs. <5% in rd3/rd3 alone); RD3-GFP expressed in rd3/rd3 rods inhibited GCAP-dependent RetGC activation in vitro and in vivo, increased RetGC levels, restored photoresponses, and rescued rods; RD3-GFP localized predominantly to inner segments where it competes with GCAPs to prevent premature cyclase activation.","method":"Genetic epistasis (rd3/rd3 × GCAPs−/− double mutant), transgenic RD3-GFP expression, ERG, immunofluorescence, in vitro RetGC activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double-knockout rescue, transgenic in vivo rescue, in vitro assay; multiple orthogonal methods","pmids":["31346032"],"is_preprint":false},{"year":2020,"finding":"Two distinct surface-exposed clusters on RD3—one adjacent to Leu63 in the loop connecting helices 1 and 2, and one surrounding Arg101 on helix 3—are required for high-affinity inhibitory binding to RetGC1; single substitutions in these clusters reduced IC50 up to 245-fold; deletion of 49 C-terminal residues did not affect apparent affinity; inactivation of both clusters completely disabled RD3 binding to RetGC1 in living HEK293 cells.","method":"Systematic single substitution/deletion mutagenesis of 133 surface-exposed residues, in vitro reconstitution with purified GCAP1-activated human RetGC1, co-localization in HEK293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — comprehensive mutagenesis of 133 residues with in vitro reconstitution and cell-based validation","pmids":["32493772"],"is_preprint":false},{"year":2020,"finding":"In rd3 mice, GCAPs are retained at the inner segment in their Ca2+-free guanylate cyclase-activator state, inducing endoplasmic reticulum stress and mitochondrial swelling that precede photoreceptor cell death; GCAPs ablation substantially delays retinal degeneration in rd3 mice (photoreceptor number halved at ~8 months vs. 6 weeks in rd3 alone); ER stress and mitochondrial swelling are early hallmarks rescued by GCAPs ablation.","method":"Genetic epistasis (rd3/rd3 × GCAPs−/− double mutant), immunofluorescence, ER stress markers, electron microscopy, cell counting","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with well-defined morphological and biochemical phenotypes, independently corroborates the JBC 2019 finding","pmids":["31980596"],"is_preprint":false},{"year":2026,"finding":"GCAP1 interacts directly with RD3 in a strongly Ca2+-dependent manner (Ca2+-bound GCAP1 KD ~1.6 μM; Mg2+-bound GCAP1 binds much more weakly); the IRD-associated E111V GCAP1 mutation completely abolishes RD3 binding; GCAP1 residues mediating RD3 binding overlap with those involved in GCAP1 dimerization and GC1 interaction; RD3 inhibits GC1 via dual mechanisms—direct binding to GC1 and GCAP1-mediated inhibition; GCAP1, RD3, and GC1 co-localize at photoreceptor inner segments and synaptic terminals.","method":"NMR spectroscopy, surface plasmon resonance, AlphaFold3 modeling, enzymatic activity assays, immunohistochemistry","journal":"International journal of biological macromolecules","confidence":"High","confidence_rationale":"Tier 1 — NMR + SPR binding kinetics + mutagenesis + functional assay in a single study","pmids":["41819313"],"is_preprint":false}],"current_model":"RD3 is an evolutionarily conserved 23 kDa photoreceptor protein that physically binds to retinal membrane guanylyl cyclases GC1 and GC2 via a central binding interface (Lys87–Leu122, with two key surface-exposed clusters near Leu63 and Arg101) to serve two coupled functions: (1) it potently inhibits RetGC catalytic activity and GCAP-stimulated cyclase activation in a noncompetitive, Ca2+-independent manner, preventing premature cGMP synthesis in the inner segment; and (2) it promotes ER export and trafficking of GC1/GC2 to photoreceptor outer segments, with loss of RD3 causing retention of GC1/GC2 in the ER, unchecked GCAP-dependent RetGC activation at low Ca2+, ER stress, and ultimately photoreceptor degeneration as seen in LCA12 patients, rd3 mice, and rcd2 collies."},"narrative":{"teleology":[{"year":2006,"claim":"Initial characterization showed RD3 localizes to subnuclear regions near PML bodies in heterologous cells and that the LCA12-associated truncation destabilizes the protein, establishing that disease-linked mutations disrupt RD3 stability.","evidence":"Transient transfection of COS-1 cells with RD3-fusion constructs, immunofluorescence","pmids":["17186464"],"confidence":"Medium","gaps":["Overexpression in non-photoreceptor cells; subnuclear localization not confirmed in photoreceptors","No functional assay linking localization to mechanism","No interaction partner identified"]},{"year":2010,"claim":"Identification of GC1 and GC2 as direct binding partners of RD3 in photoreceptors resolved the molecular target, and demonstration that rd3-null retinas lack outer-segment GC1/GC2 established RD3 as essential for cyclase trafficking from the ER.","evidence":"Reciprocal co-immunoprecipitation from retinal and HEK293 cell extracts, immunofluorescence of rd3 mouse retinas, ER-to-vesicle trafficking assays","pmids":["21078983"],"confidence":"High","gaps":["Mechanism by which RD3 promotes ER export not defined","Whether RD3 also regulates GC catalytic activity unknown at this point"]},{"year":2011,"claim":"Reconstitution of RD3 with purified RetGC revealed that RD3 is a high-affinity allosteric inhibitor of cyclase activity, acting noncompetitively and Ca²⁺-independently, and that LCA12 mutations abolish this inhibition—establishing a dual trafficking/inhibitory role.","evidence":"In vitro RetGC activity assays with purified components, site-directed mutagenesis of disease-associated RD3 variants","pmids":["21928830"],"confidence":"High","gaps":["Binding interface on RD3 not mapped","Relative contribution of trafficking vs. inhibitory function to photoreceptor survival unclear"]},{"year":2013,"claim":"AAV-mediated RD3 gene replacement in rd3 mice restored GC1/GC2 outer-segment localization, photoreceptor survival, and visual function, providing in vivo proof that RD3 is both necessary and sufficient for photoreceptor rescue.","evidence":"Subretinal AAV8-Rd3 injection, electroretinography, immunofluorescence, photoreceptor cell counting over 7 months","pmids":["23740938"],"confidence":"High","gaps":["Long-term durability beyond 7 months not assessed","Relative rescue of rods vs. cones not fully characterized"]},{"year":2016,"claim":"Systematic mutagenesis of conserved RD3 regions mapped the primary RetGC-binding interface to residues Lys87–Leu122, with Cys93 critical for co-localization, identifying the structural determinants of cyclase regulation.","evidence":"Alanine/scramble mutagenesis across 22 conserved regions, in vitro RetGC inhibition assays, HEK293 co-localization","pmids":["27471269"],"confidence":"High","gaps":["Three-dimensional structure of RD3 not yet available","Whether binding interface is also the trafficking-competence determinant unknown"]},{"year":2018,"claim":"The NMR solution structure of RD3 revealed an elongated four-helix bundle and showed that RetGC-binding residues cluster on a contiguous surface between helices 2–4, providing the first structural framework for understanding cyclase regulation.","evidence":"NMR structure determination of RD3 residues 18–160, mutagenesis-validated binding assays","pmids":["30559291"],"confidence":"High","gaps":["No co-structure of RD3–RetGC complex","Structural basis for trafficking function vs. inhibitory function not resolved"]},{"year":2019,"claim":"Genetic epistasis demonstrated that the proximate cause of photoreceptor death in rd3 mice is unchecked GCAP-dependent RetGC activation at low Ca²⁺: ablation of GCAPs rescued ~70% of photoreceptors, and transgenic RD3-GFP in inner segments competed with GCAPs for RetGC binding, restoring visual function.","evidence":"rd3/rd3 × GCAPs−/− double mutant mice, transgenic RD3-GFP expression, ERG, in vitro RetGC assay","pmids":["31346032"],"confidence":"High","gaps":["Whether RD3 and GCAPs bind overlapping or distinct sites on RetGC not determined","Stoichiometry of the RD3–RetGC complex unknown"]},{"year":2020,"claim":"Comprehensive surface-residue mutagenesis (133 positions) resolved two discrete surface-exposed clusters on RD3 (near Leu63 and Arg101) required for high-affinity RetGC1 inhibition, while showing the C-terminal 49 residues are dispensable—refining the minimal binding determinants.","evidence":"Systematic single-substitution mutagenesis, in vitro reconstitution with GCAP1-activated RetGC1, HEK293 co-localization","pmids":["32493772"],"confidence":"High","gaps":["Whether the two clusters engage one or two distinct sites on RetGC unknown","No direct trafficking assay performed for surface mutants"]},{"year":2020,"claim":"Characterization of ER stress and mitochondrial swelling as early pathological events in rd3 retinas—rescued by GCAPs ablation—established the cell-biological mechanism linking unregulated cGMP synthesis to photoreceptor apoptosis.","evidence":"ER stress markers, electron microscopy, genetic epistasis (rd3 × GCAPs−/−), photoreceptor counting","pmids":["31980596"],"confidence":"High","gaps":["Whether ER stress is caused directly by cGMP overproduction or indirectly by mislocalized GC remains unclear","Downstream apoptotic pathway not fully delineated"]},{"year":2026,"claim":"Discovery that GCAP1 directly binds RD3 in a Ca²⁺-dependent manner (KD ~1.6 µM for Ca²⁺-bound GCAP1) revealed a dual inhibition mechanism whereby RD3 suppresses RetGC both directly and via GCAP1 sequestration, and the IRD-associated E111V GCAP1 mutation abolishes this interaction.","evidence":"NMR spectroscopy, surface plasmon resonance, enzymatic activity assays, immunohistochemistry of mouse retinas","pmids":["41819313"],"confidence":"High","gaps":["Whether a ternary RD3–GCAP1–GC1 complex forms in vivo is unresolved","Physiological relevance of Ca²⁺-dependent vs. Ca²⁺-independent RD3 interactions not tested in photoreceptors"]},{"year":null,"claim":"Key unresolved questions include the atomic structure of RD3 in complex with RetGC and/or GCAP1, the mechanism by which RD3 promotes ER export (whether via a specific cargo receptor or direct coat interaction), and whether the inhibitory and trafficking functions of RD3 are mechanistically separable.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal or cryo-EM structure of RD3–RetGC complex","ER export mechanism (coat interaction, cargo receptor) completely uncharacterized","Separation-of-function mutants distinguishing trafficking from inhibition not yet identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,4,6,7,9]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,3,8]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,9]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[3,6]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[1,3]}],"complexes":[],"partners":["GUCY2D","GUCY2F","GUCA1A"],"other_free_text":[]},"mechanistic_narrative":"RD3 is a photoreceptor-specific regulatory protein that controls retinal guanylyl cyclase (RetGC) activity and trafficking, thereby safeguarding photoreceptor viability. RD3 physically binds GC1 and GC2 through two surface-exposed clusters (near Leu63 and Arg101) on an elongated four-helix bundle, functioning as a potent noncompetitive inhibitor that suppresses both basal and GCAP-stimulated RetGC catalytic activity at submicromolar concentrations [PMID:21928830, PMID:32493772, PMID:30559291]. RD3 also promotes ER export and outer-segment trafficking of GC1/GC2; in rd3-null photoreceptors, guanylyl cyclases are retained in the inner segment ER where unchecked GCAP-dependent activation at low Ca²⁺ triggers ER stress, mitochondrial swelling, and photoreceptor degeneration—a mechanism confirmed by genetic epistasis showing that GCAPs ablation substantially rescues rd3 photoreceptors [PMID:21078983, PMID:31346032, PMID:31980596]. Loss-of-function mutations in RD3 cause Leber congenital amaurosis type 12 (LCA12), and AAV-mediated RD3 gene replacement restores GC trafficking, photoreceptor survival, and visual function in the rd3 mouse [PMID:23740938]."},"prefetch_data":{"uniprot":{"accession":"Q7Z3Z2","full_name":"Protein RD3","aliases":["Retinal degeneration protein 3"],"length_aa":195,"mass_kda":22.7,"function":"Plays a critical role in the regulation of enzymes involved in nucleotide cycle in photoreceptors (PubMed:21078983, PubMed:21928830, PubMed:27471269, PubMed:29515371, PubMed:30559291). Inhibits the basal catalytic activity and the GCAP-stimulated activity of GUCY2D and GUCY2F, two retinal guanylyl cyclases involved in the production of cGMP in photoreceptors (PubMed:21928830, PubMed:27471269, PubMed:29515371, PubMed:30559291). Involved in the transport of GUCY2D and GUCY2F to their target sites in the photoreceptor outer segment (PubMed:21078983). Up-regulates the activity of GUK1, a kinase that also plays an essential role for recycling GMP and indirectly, cGMP (PubMed:29515371). Plays an important role for the survival of rods and cones in the retina (By similarity)","subcellular_location":"Cell projection, cilium, photoreceptor outer segment; Photoreceptor inner segment; Endosome; Nucleus; Cytoplasm; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/Q7Z3Z2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RD3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RD3","total_profiled":1310},"omim":[{"mim_id":"620079","title":"LONG INTERGENIC NONCODING RNA 467; LINC00467","url":"https://www.omim.org/entry/620079"},{"mim_id":"610612","title":"LEBER CONGENITAL AMAUROSIS 12; LCA12","url":"https://www.omim.org/entry/610612"},{"mim_id":"600179","title":"GUANYLATE CYCLASE 2D, RETINAL; GUCY2D","url":"https://www.omim.org/entry/600179"},{"mim_id":"204000","title":"LEBER CONGENITAL AMAUROSIS 1; LCA1","url":"https://www.omim.org/entry/204000"},{"mim_id":"180040","title":"RD3 REGULATOR OF GUCY2D; RD3","url":"https://www.omim.org/entry/180040"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":43.8}],"url":"https://www.proteinatlas.org/search/RD3"},"hgnc":{"alias_symbol":["LCA12"],"prev_symbol":["C1orf36"]},"alphafold":{"accession":"Q7Z3Z2","domains":[{"cath_id":"-","chopping":"21-61_72-145","consensus_level":"high","plddt":94.781,"start":21,"end":145}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z3Z2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z3Z2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z3Z2-F1-predicted_aligned_error_v6.png","plddt_mean":81.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RD3","jax_strain_url":"https://www.jax.org/strain/search?query=RD3"},"sequence":{"accession":"Q7Z3Z2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q7Z3Z2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q7Z3Z2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z3Z2"}},"corpus_meta":[{"pmid":"17186464","id":"PMC_17186464","title":"Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17186464","citation_count":99,"is_preprint":false},{"pmid":"21078983","id":"PMC_21078983","title":"RD3, the protein associated with Leber congenital amaurosis type 12, is required for guanylate cyclase trafficking in photoreceptor cells.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21078983","citation_count":85,"is_preprint":false},{"pmid":"130474","id":"PMC_130474","title":"The fine structure of neoplastic invasion: invasion of liver, skeletal muscle and lymphatic vessels by the Rd/3 tumour.","date":"1976","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/130474","citation_count":72,"is_preprint":false},{"pmid":"8486383","id":"PMC_8486383","title":"New mouse primary retinal degeneration (rd-3).","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8486383","citation_count":61,"is_preprint":false},{"pmid":"23740938","id":"PMC_23740938","title":"RD3 gene delivery restores guanylate cyclase localization and rescues photoreceptors in the Rd3 mouse model of Leber congenital amaurosis 12.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23740938","citation_count":48,"is_preprint":false},{"pmid":"19130129","id":"PMC_19130129","title":"Canine RD3 mutation establishes rod-cone dysplasia type 2 (rcd2) as ortholog of human and murine rd3.","date":"2009","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/19130129","citation_count":46,"is_preprint":false},{"pmid":"21928830","id":"PMC_21928830","title":"Retinal degeneration 3 (RD3) protein inhibits catalytic activity of retinal membrane guanylyl cyclase (RetGC) and its stimulation by activating proteins.","date":"2011","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21928830","citation_count":42,"is_preprint":false},{"pmid":"27471269","id":"PMC_27471269","title":"Functional Study and Mapping Sites for Interaction with the Target Enzyme in Retinal Degeneration 3 (RD3) Protein.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27471269","citation_count":31,"is_preprint":false},{"pmid":"24904271","id":"PMC_24904271","title":"Insights into the role of RD3 in guanylate cyclase trafficking, photoreceptor degeneration, and Leber congenital amaurosis.","date":"2014","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24904271","citation_count":26,"is_preprint":false},{"pmid":"18344445","id":"PMC_18344445","title":"Genetic modifiers of retinal degeneration in the rd3 mouse.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/18344445","citation_count":22,"is_preprint":false},{"pmid":"22531706","id":"PMC_22531706","title":"Mutations in RD3 are associated with an extremely rare and severe form of early onset retinal dystrophy.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22531706","citation_count":21,"is_preprint":false},{"pmid":"21036348","id":"PMC_21036348","title":"Photoinactivation of F. nucleatum and P. gingivalis using the ruthenium-based RD3 sensitizer and a conventional halogen lamp.","date":"2010","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/21036348","citation_count":21,"is_preprint":false},{"pmid":"16469183","id":"PMC_16469183","title":"Morphological characterization of the retinal degeneration in three strains of mice carrying the rd-3 mutation.","date":"2005","source":"Visual neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16469183","citation_count":19,"is_preprint":false},{"pmid":"10103176","id":"PMC_10103176","title":"Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice.","date":"1999","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/10103176","citation_count":18,"is_preprint":false},{"pmid":"33537894","id":"PMC_33537894","title":"Regulation of retinal membrane guanylyl cyclase (RetGC) by negative calcium feedback and RD3 protein.","date":"2021","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33537894","citation_count":17,"is_preprint":false},{"pmid":"26375249","id":"PMC_26375249","title":"RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26375249","citation_count":16,"is_preprint":false},{"pmid":"30559291","id":"PMC_30559291","title":"Retinal degeneration 3 (RD3) protein, a retinal guanylyl cyclase regulator, forms a monomeric and elongated four-helix bundle.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30559291","citation_count":16,"is_preprint":false},{"pmid":"23308101","id":"PMC_23308101","title":"Union makes strength: a worldwide collaborative genetic and clinical study to provide a comprehensive survey of RD3 mutations and delineate the associated phenotype.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23308101","citation_count":14,"is_preprint":false},{"pmid":"11529559","id":"PMC_11529559","title":"Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).","date":"2001","source":"Microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11529559","citation_count":13,"is_preprint":false},{"pmid":"31346032","id":"PMC_31346032","title":"Retinal guanylyl cyclase activation by calcium sensor proteins mediates photoreceptor degeneration in an rd3 mouse model of congenital human blindness.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31346032","citation_count":11,"is_preprint":false},{"pmid":"12914764","id":"PMC_12914764","title":"Identification and characterization of C1orf36, a transcript highly expressed in photoreceptor cells, and mutation analysis in retinitis pigmentosa.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12914764","citation_count":11,"is_preprint":false},{"pmid":"31980596","id":"PMC_31980596","title":"GCAP neuronal calcium sensor proteins mediate photoreceptor cell death in the rd3 mouse model of LCA12 congenital blindness by involving endoplasmic reticulum stress.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31980596","citation_count":10,"is_preprint":false},{"pmid":"10384036","id":"PMC_10384036","title":"Genetic and physical maps of the mouse rd3 locus; exclusion of the ortholog of USH2A.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10384036","citation_count":10,"is_preprint":false},{"pmid":"29030614","id":"PMC_29030614","title":"Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29030614","citation_count":9,"is_preprint":false},{"pmid":"31409909","id":"PMC_31409909","title":"De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31409909","citation_count":9,"is_preprint":false},{"pmid":"10423534","id":"PMC_10423534","title":"Determination of the solution structure of the N-domain plus linker of Antarctic eel pout antifreeze protein RD3.","date":"1999","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10423534","citation_count":9,"is_preprint":false},{"pmid":"32493772","id":"PMC_32493772","title":"Two clusters of surface-exposed amino acid residues enable high-affinity binding of retinal degeneration-3 (RD3) protein to retinal guanylyl cyclase.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32493772","citation_count":7,"is_preprint":false},{"pmid":"18459801","id":"PMC_18459801","title":"Two domains of RD3 antifreeze protein diffuse independently.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18459801","citation_count":7,"is_preprint":false},{"pmid":"36157073","id":"PMC_36157073","title":"Structural basis of retinal membrane guanylate cyclase regulation by GCAP1 and RD3.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36157073","citation_count":6,"is_preprint":false},{"pmid":"25679013","id":"PMC_25679013","title":"RD3: a challenge and a promise.","date":"2013","source":"JSM biotechnology & biomedical engineering","url":"https://pubmed.ncbi.nlm.nih.gov/25679013","citation_count":6,"is_preprint":false},{"pmid":"11820507","id":"PMC_11820507","title":"Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat.","date":"2002","source":"Xenobiotica; the fate of foreign compounds in biological systems","url":"https://pubmed.ncbi.nlm.nih.gov/11820507","citation_count":3,"is_preprint":false},{"pmid":"32083505","id":"PMC_32083505","title":"Optical coherence tomography and fundus autofluorescence imaging in an infant with RD3-related leber congenital amaurosis.","date":"2020","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32083505","citation_count":3,"is_preprint":false},{"pmid":"29327102","id":"PMC_29327102","title":"Chemical shift assignments of retinal degeneration 3 protein (RD3).","date":"2018","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/29327102","citation_count":2,"is_preprint":false},{"pmid":"40188639","id":"PMC_40188639","title":"Generation and validation of a Leber Congenital Amaurosis, Type 12 patient-specific iPSC line (LVPEIi006-B) with a splice-site mutation in RD3 and an isogenic mutation-corrected iPSC line (LVPEIi006-B-1).","date":"2025","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/40188639","citation_count":1,"is_preprint":false},{"pmid":"41819313","id":"PMC_41819313","title":"Structural and functional investigation of RD3-GCAP1 interaction in retinal photoreceptors under normal and disease conditions.","date":"2026","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41819313","citation_count":0,"is_preprint":false},{"pmid":"38479331","id":"PMC_38479331","title":"Generation of Leber congenital amaurosis, type 12 patient-specific induced pluripotent stem cell line (LVPEIi006-A), harboring a homozygous mutation in RD3.","date":"2024","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/38479331","citation_count":0,"is_preprint":false},{"pmid":"41619263","id":"PMC_41619263","title":"Cellular Identity Crisis: RD3 Loss Fuels Plasticity and Immune Silence in Progressive Neuroblastoma.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41619263","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19458,"output_tokens":3076,"usd":0.052257},"stage2":{"model":"claude-opus-4-6","input_tokens":6446,"output_tokens":2748,"usd":0.151395},"total_usd":0.203652,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"RD3 protein exhibits subnuclear localization adjacent to promyelocytic leukemia (PML) bodies in transiently transfected COS-1 cells; the truncated mutant RD3 protein is rapidly degraded in COS-1 cells.\",\n      \"method\": \"Transient transfection of COS-1 cells with RD3-fusion protein, immunofluorescence microscopy\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single transfection experiment, localization without full functional link established\",\n      \"pmids\": [\"17186464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RD3 colocalizes and physically interacts with guanylate cyclases GC1 and GC2 in rod and cone photoreceptor cells; in rd3 mice deficient in RD3, GC1 and GC2 are undetectable in photoreceptors; cell expression studies show RD3 mediates export of GC1 from the endoplasmic reticulum to endosomal vesicles, and the C-terminus of GC1 is required for RD3 binding.\",\n      \"method\": \"Co-immunoprecipitation from retinal cell extracts and HEK293 cells, immunofluorescence microscopy of rd3 mouse retinas, cell expression trafficking assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, loss-of-function mouse model with defined cellular phenotype, trafficking assay; replicated in follow-up studies\",\n      \"pmids\": [\"21078983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RD3 is a high-affinity allosteric inhibitor of retinal membrane guanylyl cyclase (RetGC), suppressing basal RetGC activity in a noncompetitive manner at submicromolar concentrations and inhibiting GCAP-stimulated RetGC activity at low Ca2+; disease-associated mutations (including the LCA12 C-terminal truncation and G57V) reduce RD3's affinity for RetGC1 or abolish inhibitory activity; inhibition of RetGC by RD3 may function to block cyclase activity during its maturation/trafficking.\",\n      \"method\": \"In vitro RetGC activity assays with purified or expressed RD3 and RetGC1/GCAP, site-directed mutagenesis of disease-associated RD3 variants, HEK293 cell expression\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution assay with mutagenesis, multiple disease-associated mutants tested, replicated by subsequent studies\",\n      \"pmids\": [\"21928830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"AAV8-mediated delivery of Rd3 cDNA to rd3 mouse photoreceptors restores GC1 and GC2 translocation from the ER to rod and cone outer segments, rescues photoreceptor survival for at least 7 months, and restores rod and cone visual function as measured by ERG; this confirms RD3's essential role in GC exit from the ER and trafficking to outer segments.\",\n      \"method\": \"Subretinal AAV injection, immunofluorescence microscopy, electroretinography, photoreceptor cell counting\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene rescue with multiple orthogonal readouts (immunolocalization, ERG, cell survival), clear functional consequence\",\n      \"pmids\": [\"23740938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The main RetGC-binding interface on RD3 required for negative regulation of the cyclase maps to the Lys87–Leu122 central region; substitutions in four conserved regions—(87)KIHP(90), (93)CGPAI(97), (99)RFRQ(102), and (119)RSVL(122)—reduced apparent RD3 affinity for the cyclase 180–700-fold; mutations in (93)CGPAI(97) (especially Cys93) most drastically disrupted RD3 co-localization with RetGC1 in HEK293 cells.\",\n      \"method\": \"Alanine/sequence-scramble mutagenesis of conserved RD3 regions, in vitro RetGC inhibition assays, co-localization in co-transfected HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis across 22 regions combined with in vitro activity assay and cell co-localization\",\n      \"pmids\": [\"27471269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NMR solution structure of human RD3 (residues 18–160) reveals an elongated four-helix bundle (~70 Å × 30 Å) with a long unstructured loop between helices 1 and 2; residues previously implicated in RetGC binding map to a localized contiguous area involving the loop between helices 2 and 3 and adjacent parts of helices 3 and 4; mutagenesis of hydrophobic core residues (Trp85, Phe29, Glu32, Cys93) validated the structure and its relevance to RetGC1 binding affinity.\",\n      \"method\": \"NMR solution structure determination, site-directed mutagenesis, in vitro RetGC binding/inhibition assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with mutagenesis functional validation; monomeric soluble variant used\",\n      \"pmids\": [\"30559291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RD3 protects photoreceptors from degeneration by competing with GCAPs for RetGC binding; in rd3/rd3 retinas, residual RetGC is stimulated by GCAPs at low Ca2+; ablation of GCAPs in rd3/rd3 mice rescued ~70% of photoreceptors past 6 months (vs. <5% in rd3/rd3 alone); RD3-GFP expressed in rd3/rd3 rods inhibited GCAP-dependent RetGC activation in vitro and in vivo, increased RetGC levels, restored photoresponses, and rescued rods; RD3-GFP localized predominantly to inner segments where it competes with GCAPs to prevent premature cyclase activation.\",\n      \"method\": \"Genetic epistasis (rd3/rd3 × GCAPs−/− double mutant), transgenic RD3-GFP expression, ERG, immunofluorescence, in vitro RetGC activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double-knockout rescue, transgenic in vivo rescue, in vitro assay; multiple orthogonal methods\",\n      \"pmids\": [\"31346032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Two distinct surface-exposed clusters on RD3—one adjacent to Leu63 in the loop connecting helices 1 and 2, and one surrounding Arg101 on helix 3—are required for high-affinity inhibitory binding to RetGC1; single substitutions in these clusters reduced IC50 up to 245-fold; deletion of 49 C-terminal residues did not affect apparent affinity; inactivation of both clusters completely disabled RD3 binding to RetGC1 in living HEK293 cells.\",\n      \"method\": \"Systematic single substitution/deletion mutagenesis of 133 surface-exposed residues, in vitro reconstitution with purified GCAP1-activated human RetGC1, co-localization in HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive mutagenesis of 133 residues with in vitro reconstitution and cell-based validation\",\n      \"pmids\": [\"32493772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In rd3 mice, GCAPs are retained at the inner segment in their Ca2+-free guanylate cyclase-activator state, inducing endoplasmic reticulum stress and mitochondrial swelling that precede photoreceptor cell death; GCAPs ablation substantially delays retinal degeneration in rd3 mice (photoreceptor number halved at ~8 months vs. 6 weeks in rd3 alone); ER stress and mitochondrial swelling are early hallmarks rescued by GCAPs ablation.\",\n      \"method\": \"Genetic epistasis (rd3/rd3 × GCAPs−/− double mutant), immunofluorescence, ER stress markers, electron microscopy, cell counting\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with well-defined morphological and biochemical phenotypes, independently corroborates the JBC 2019 finding\",\n      \"pmids\": [\"31980596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GCAP1 interacts directly with RD3 in a strongly Ca2+-dependent manner (Ca2+-bound GCAP1 KD ~1.6 μM; Mg2+-bound GCAP1 binds much more weakly); the IRD-associated E111V GCAP1 mutation completely abolishes RD3 binding; GCAP1 residues mediating RD3 binding overlap with those involved in GCAP1 dimerization and GC1 interaction; RD3 inhibits GC1 via dual mechanisms—direct binding to GC1 and GCAP1-mediated inhibition; GCAP1, RD3, and GC1 co-localize at photoreceptor inner segments and synaptic terminals.\",\n      \"method\": \"NMR spectroscopy, surface plasmon resonance, AlphaFold3 modeling, enzymatic activity assays, immunohistochemistry\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR + SPR binding kinetics + mutagenesis + functional assay in a single study\",\n      \"pmids\": [\"41819313\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RD3 is an evolutionarily conserved 23 kDa photoreceptor protein that physically binds to retinal membrane guanylyl cyclases GC1 and GC2 via a central binding interface (Lys87–Leu122, with two key surface-exposed clusters near Leu63 and Arg101) to serve two coupled functions: (1) it potently inhibits RetGC catalytic activity and GCAP-stimulated cyclase activation in a noncompetitive, Ca2+-independent manner, preventing premature cGMP synthesis in the inner segment; and (2) it promotes ER export and trafficking of GC1/GC2 to photoreceptor outer segments, with loss of RD3 causing retention of GC1/GC2 in the ER, unchecked GCAP-dependent RetGC activation at low Ca2+, ER stress, and ultimately photoreceptor degeneration as seen in LCA12 patients, rd3 mice, and rcd2 collies.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RD3 is a photoreceptor-specific regulatory protein that controls retinal guanylyl cyclase (RetGC) activity and trafficking, thereby safeguarding photoreceptor viability. RD3 physically binds GC1 and GC2 through two surface-exposed clusters (near Leu63 and Arg101) on an elongated four-helix bundle, functioning as a potent noncompetitive inhibitor that suppresses both basal and GCAP-stimulated RetGC catalytic activity at submicromolar concentrations [PMID:21928830, PMID:32493772, PMID:30559291]. RD3 also promotes ER export and outer-segment trafficking of GC1/GC2; in rd3-null photoreceptors, guanylyl cyclases are retained in the inner segment ER where unchecked GCAP-dependent activation at low Ca²⁺ triggers ER stress, mitochondrial swelling, and photoreceptor degeneration—a mechanism confirmed by genetic epistasis showing that GCAPs ablation substantially rescues rd3 photoreceptors [PMID:21078983, PMID:31346032, PMID:31980596]. Loss-of-function mutations in RD3 cause Leber congenital amaurosis type 12 (LCA12), and AAV-mediated RD3 gene replacement restores GC trafficking, photoreceptor survival, and visual function in the rd3 mouse [PMID:23740938].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Initial characterization showed RD3 localizes to subnuclear regions near PML bodies in heterologous cells and that the LCA12-associated truncation destabilizes the protein, establishing that disease-linked mutations disrupt RD3 stability.\",\n      \"evidence\": \"Transient transfection of COS-1 cells with RD3-fusion constructs, immunofluorescence\",\n      \"pmids\": [\"17186464\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression in non-photoreceptor cells; subnuclear localization not confirmed in photoreceptors\", \"No functional assay linking localization to mechanism\", \"No interaction partner identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of GC1 and GC2 as direct binding partners of RD3 in photoreceptors resolved the molecular target, and demonstration that rd3-null retinas lack outer-segment GC1/GC2 established RD3 as essential for cyclase trafficking from the ER.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation from retinal and HEK293 cell extracts, immunofluorescence of rd3 mouse retinas, ER-to-vesicle trafficking assays\",\n      \"pmids\": [\"21078983\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which RD3 promotes ER export not defined\", \"Whether RD3 also regulates GC catalytic activity unknown at this point\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Reconstitution of RD3 with purified RetGC revealed that RD3 is a high-affinity allosteric inhibitor of cyclase activity, acting noncompetitively and Ca²⁺-independently, and that LCA12 mutations abolish this inhibition—establishing a dual trafficking/inhibitory role.\",\n      \"evidence\": \"In vitro RetGC activity assays with purified components, site-directed mutagenesis of disease-associated RD3 variants\",\n      \"pmids\": [\"21928830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface on RD3 not mapped\", \"Relative contribution of trafficking vs. inhibitory function to photoreceptor survival unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"AAV-mediated RD3 gene replacement in rd3 mice restored GC1/GC2 outer-segment localization, photoreceptor survival, and visual function, providing in vivo proof that RD3 is both necessary and sufficient for photoreceptor rescue.\",\n      \"evidence\": \"Subretinal AAV8-Rd3 injection, electroretinography, immunofluorescence, photoreceptor cell counting over 7 months\",\n      \"pmids\": [\"23740938\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term durability beyond 7 months not assessed\", \"Relative rescue of rods vs. cones not fully characterized\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Systematic mutagenesis of conserved RD3 regions mapped the primary RetGC-binding interface to residues Lys87–Leu122, with Cys93 critical for co-localization, identifying the structural determinants of cyclase regulation.\",\n      \"evidence\": \"Alanine/scramble mutagenesis across 22 conserved regions, in vitro RetGC inhibition assays, HEK293 co-localization\",\n      \"pmids\": [\"27471269\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Three-dimensional structure of RD3 not yet available\", \"Whether binding interface is also the trafficking-competence determinant unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The NMR solution structure of RD3 revealed an elongated four-helix bundle and showed that RetGC-binding residues cluster on a contiguous surface between helices 2–4, providing the first structural framework for understanding cyclase regulation.\",\n      \"evidence\": \"NMR structure determination of RD3 residues 18–160, mutagenesis-validated binding assays\",\n      \"pmids\": [\"30559291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-structure of RD3–RetGC complex\", \"Structural basis for trafficking function vs. inhibitory function not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genetic epistasis demonstrated that the proximate cause of photoreceptor death in rd3 mice is unchecked GCAP-dependent RetGC activation at low Ca²⁺: ablation of GCAPs rescued ~70% of photoreceptors, and transgenic RD3-GFP in inner segments competed with GCAPs for RetGC binding, restoring visual function.\",\n      \"evidence\": \"rd3/rd3 × GCAPs−/− double mutant mice, transgenic RD3-GFP expression, ERG, in vitro RetGC assay\",\n      \"pmids\": [\"31346032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RD3 and GCAPs bind overlapping or distinct sites on RetGC not determined\", \"Stoichiometry of the RD3–RetGC complex unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Comprehensive surface-residue mutagenesis (133 positions) resolved two discrete surface-exposed clusters on RD3 (near Leu63 and Arg101) required for high-affinity RetGC1 inhibition, while showing the C-terminal 49 residues are dispensable—refining the minimal binding determinants.\",\n      \"evidence\": \"Systematic single-substitution mutagenesis, in vitro reconstitution with GCAP1-activated RetGC1, HEK293 co-localization\",\n      \"pmids\": [\"32493772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the two clusters engage one or two distinct sites on RetGC unknown\", \"No direct trafficking assay performed for surface mutants\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Characterization of ER stress and mitochondrial swelling as early pathological events in rd3 retinas—rescued by GCAPs ablation—established the cell-biological mechanism linking unregulated cGMP synthesis to photoreceptor apoptosis.\",\n      \"evidence\": \"ER stress markers, electron microscopy, genetic epistasis (rd3 × GCAPs−/−), photoreceptor counting\",\n      \"pmids\": [\"31980596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ER stress is caused directly by cGMP overproduction or indirectly by mislocalized GC remains unclear\", \"Downstream apoptotic pathway not fully delineated\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Discovery that GCAP1 directly binds RD3 in a Ca²⁺-dependent manner (KD ~1.6 µM for Ca²⁺-bound GCAP1) revealed a dual inhibition mechanism whereby RD3 suppresses RetGC both directly and via GCAP1 sequestration, and the IRD-associated E111V GCAP1 mutation abolishes this interaction.\",\n      \"evidence\": \"NMR spectroscopy, surface plasmon resonance, enzymatic activity assays, immunohistochemistry of mouse retinas\",\n      \"pmids\": [\"41819313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether a ternary RD3–GCAP1–GC1 complex forms in vivo is unresolved\", \"Physiological relevance of Ca²⁺-dependent vs. Ca²⁺-independent RD3 interactions not tested in photoreceptors\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic structure of RD3 in complex with RetGC and/or GCAP1, the mechanism by which RD3 promotes ER export (whether via a specific cargo receptor or direct coat interaction), and whether the inhibitory and trafficking functions of RD3 are mechanistically separable.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No co-crystal or cryo-EM structure of RD3–RetGC complex\", \"ER export mechanism (coat interaction, cargo receptor) completely uncharacterized\", \"Separation-of-function mutants distinguishing trafficking from inhibition not yet identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 4, 6, 7, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 3, 8]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009536\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [3, 6]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GUCY2D\", \"GUCY2F\", \"GUCA1A\"],\n    \"other_free_text\": []\n  }\n}\n```"}